The liver malignant neoplasms mortality rate for Canadian men is projected to rise steadily from 12.6 deaths per 100,000 in 2024 to 13.6 by 2028. This forecast indicates a consistent annual increase with a Compound Annual Growth Rate (CAGR) over five years. The period from 2024 to 2028 shows a progressive uptick, reflecting approximately a 1.9% annual growth rate in mortality per year. This sustained increase suggests key factors such as demographic shifts and potential healthcare challenges are contributing to this trend.

Future trends to watch for include:

Advancements in early detection and treatment that can impact mortality rates.
Public health initiatives focusing on lifestyle factors contributing to liver cancer.
Investment in targeted therapeutic research aimed at combating liver cancer.